Markets › India › BOM › SYNCOMF

Syncom Formulations (India) Limited

BOM:SYNCOMFHealthcare

——At close · Market cap —

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Revenue	2.4	2.2	2.2	2.6	4.7	4.9	+5.2%
Cost of revenue	1.7	1.5	1.4	1.6	3.1	3.6	+16.4%
Gross profit	0.7	0.7	0.8	0.6	1.6	1.3	−16.7%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—
Selling, general & administrative	0.2	0.3	0.3	0.3	0.5	0.6	+15.7%
Selling & marketing	0.2	0.3	0.2	0.3	0.0	0.0	−100.0%
Operating expenses	0.4	0.3	0.7	0.8	0.5	0.6	+17.5%
Operating income	0.3	0.1	0.2	0.2	0.5	0.7	+44.9%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	+33.5%
Interest income	0.0	0.0	0.0	0.1	0.0	0.0	—
Other income / expense	0.1	0.1	0.1	0.1	0.2	0.3	+82.3%
Pre-tax income	0.4	0.3	0.3	0.3	0.7	1.0	+54.4%
Income tax	0.1	0.1	0.1	0.1	0.2	0.2	+53.5%
Net income	0.3	0.2	0.2	0.3	0.5	0.8	+54.6%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	0.37	0.24	0.22	0.27	0.57	0.81	+42.1%
EPS, diluted (per share)	0.37	0.23	0.22	0.27	0.57	0.81	+42.1%
EBITDA	0.5	0.3	0.3	0.4	0.7	1.1	+52.9%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.1	+36.0%
Weighted average shares (shares)	789,952,180	816,850,000	928,527,000	940,000,000	867,274,000	943,679,000	+8.8%
Weighted average diluted shares (shares)	789,952,180	873,164,000	928,527,000	940,000,000	867,274,000	943,679,000	+8.8%
Gross margin	30.2%	32.6%	36.8%	21.2%	33.9%	26.8%	−7.1 pts
Operating margin	12.0%	6.8%	6.8%	8.1%	10.5%	14.5%	+4.0 pts
Net margin	12.2%	9.1%	8.9%	9.6%	10.6%	15.6%	+5.0 pts

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.